<code id='FCCFAEE957'></code><style id='FCCFAEE957'></style>
    • <acronym id='FCCFAEE957'></acronym>
      <center id='FCCFAEE957'><center id='FCCFAEE957'><tfoot id='FCCFAEE957'></tfoot></center><abbr id='FCCFAEE957'><dir id='FCCFAEE957'><tfoot id='FCCFAEE957'></tfoot><noframes id='FCCFAEE957'>

    • <optgroup id='FCCFAEE957'><strike id='FCCFAEE957'><sup id='FCCFAEE957'></sup></strike><code id='FCCFAEE957'></code></optgroup>
        1. <b id='FCCFAEE957'><label id='FCCFAEE957'><select id='FCCFAEE957'><dt id='FCCFAEE957'><span id='FCCFAEE957'></span></dt></select></label></b><u id='FCCFAEE957'></u>
          <i id='FCCFAEE957'><strike id='FCCFAEE957'><tt id='FCCFAEE957'><pre id='FCCFAEE957'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:67
          Glaxo Smith Kline
          Akira Suemori/AP

          A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

          “The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

          advertisement

          Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          AbbVie dramatically boosts its spending on lobbying
          AbbVie dramatically boosts its spending on lobbying

          ThepharmagiantAbbViespentnearly$4milliononlobbyinginthefirstthreemonthsof2022—nearlyamilliondollarsm

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Providers still hesitate to prescribe buprenorphine, study finds

          Anurseholdstabsofbuprenorphine.EliseAmendola/APSignificantchallengesremainbeforemostAmericanclinicia